RE: "ESTIMATING THE EFFECT OF PREVENTIVE SERVICES WITH DATABASES OF ADMINISTRATIVE CLAIMS: REASONS TO BE CONCERNED".
RE: "ESTIMATING THE EFFECT OF PREVENTIVE SERVICES WITH DATABASES OF ADMINISTRATIVE CLAIMS: REASONS TO BE CONCERNED".
复制标题
回复:“利用行政索赔数据库评估预防服务的效果:需要关注的理由”。
DOI:
10.1093/aje/kwz050
复制
发表时间:
2019
影响因子:
5
通讯作者:
Weiss,NoelS
中科院分区:
文献类型:
--
作者:
Weiss,NoelS
Because colon and rectal polyps can be identified and removed during colonoscopy, performance of this test has the potential to reduce the later incidence of colorectal cancer (CRC). In their cohort study, which sought to measure the extent to which screening colonoscopy succeeded in reducing CRC incidence, García-Albéniz et al.(2) enumerated cases among Medicare enrollees beginning at the time of screening and continuing for up to 13 years thereafter. They compared this number with that expected on the basis of rates among Medicare enrollees who had not been screened at that time (irrespective of whether they had gone on to be screened at a later date). For some years, I have advocated taking steps to increase the sensitivity of epidemiologic studies—that is, to increase the likelihood of identifying an association when one truly is present (3). My commentary in this issue of the Journal (4) was stimulated by a concern that the approach used by García-Albéniz et al.(2) would lead to a blunted estimate of any true incidence reduction associated with colonoscopy screening:• CRC cases identified at the initial screening examination, already being present, could not have been prevented by polyp identification and removal during that examination.• To the extent that Medicare records failed to discriminate between a colonoscopy performed in response to signs or symptoms and one performed for screening, there would be a spuriously large number of cases in the “screened” cohort resulting from this misclassification.• To the extent that initially unscreened persons went on to be screened during follow-up, their CRC incidence rates following screening would “contaminate” the rate for truly unscreened persons.García-Albéniz et al. chose not to evaluate receipt of screening in cohort members after follow-up began, so they had to accept the impact on the results of the misclassification of screening status during this period of time (2). In my commentary, however, I made a suggestion (echoing one made several years earlier (5)) that sought to sharpen the contrast between screened and unscreened groups. Specifically, I recommended delaying the initiation of follow-up of screened persons for an interval of time corresponding to the estimated duration of occult cancer (4). The identification and removal from the analysis of screen-detected cases would give rise to a low incidence among persons who screened as negative for cancer only for this duration of time, after which a fair comparison of cancer incidence could be made between the remaining members of the screened and unscreened groups.(In the second paragraph of their letter (1), García-Albéniz et al. refer to an analysis of the 8-year cumulative incidence of CRC (6) in which the “early follow-up” of screened